Financhill
Buy
59

HALO Quote, Financials, Valuation and Earnings

Last price:
$54.13
Seasonality move :
4.55%
Day range:
$54.00 - $54.95
52-week range:
$42.01 - $70.51
Dividend yield:
0%
P/E ratio:
14.46x
P/S ratio:
6.46x
P/B ratio:
13.89x
Volume:
1.6M
Avg. volume:
2.9M
1-year change:
6.94%
Market cap:
$6.7B
Revenue:
$1B
EPS (TTM):
$3.76

Halozyme Therapeutics SEC Filings

Company Filed Form Type Description
HALO
Halozyme Therapeutics
05/07/2024 10-Q 10-Q filing on 05/07/2024 View Form
HALO
Halozyme Therapeutics
11/06/2023 10-Q 10-Q filing on 11/06/2023 View Form
HALO
Halozyme Therapeutics
08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
HALO
Halozyme Therapeutics
05/09/2023 10-Q 10-Q filing on 05/09/2023 View Form
HALO
Halozyme Therapeutics
11/08/2022 10-Q 10-Q filing on 11/08/2022 View Form
HALO
Halozyme Therapeutics
08/09/2022 10-Q 10-Q filing on 08/09/2022 View Form
HALO
Halozyme Therapeutics
05/10/2022 10-Q 10-Q filing on 05/10/2022 View Form
HALO
Halozyme Therapeutics
11/02/2021 10-Q 10-Q filing on 11/02/2021 View Form
HALO
Halozyme Therapeutics
08/09/2021 10-Q 10-Q filing on 08/09/2021 View Form
HALO
Halozyme Therapeutics
05/10/2021 10-Q 10-Q filing on 05/10/2021 View Form
HALO
Halozyme Therapeutics
11/02/2020 10-Q 10-Q filing on 11/02/2020 View Form
HALO
Halozyme Therapeutics
08/10/2020 10-Q 10-Q filing on 08/10/2020 View Form
HALO
Halozyme Therapeutics
05/11/2020 10-Q 10-Q filing on 05/11/2020 View Form
HALO
Halozyme Therapeutics
02/24/2020 10-K 10-K filing on 02/24/2020 View Form
HALO
Halozyme Therapeutics
11/12/2019 10-Q 10-Q filing on 11/12/2019 View Form
HALO
Halozyme Therapeutics
08/06/2019 10-Q 10-Q filing on 08/06/2019 View Form
HALO
Halozyme Therapeutics
05/07/2019 10-Q 10-Q filing on 05/07/2019 View Form
HALO
Halozyme Therapeutics
02/21/2019 10-K 10-K filing on 02/21/2019 View Form
HALO
Halozyme Therapeutics
11/06/2018 10-Q 10-Q filing on 11/06/2018 View Form
HALO
Halozyme Therapeutics
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
HALO
Halozyme Therapeutics
05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
HALO
Halozyme Therapeutics
02/20/2018 10-K 10-K filing on 02/20/2018 View Form
HALO
Halozyme Therapeutics
11/07/2017 10-Q 10-Q filing on 11/07/2017 View Form
HALO
Halozyme Therapeutics
08/08/2017 10-Q 10-Q filing on 08/08/2017 View Form
HALO
Halozyme Therapeutics
05/09/2017 10-Q 10-Q filing on 05/09/2017 View Form
HALO
Halozyme Therapeutics
02/28/2017 10-K 10-K filing on 02/28/2017 View Form
HALO
Halozyme Therapeutics
11/07/2016 10-Q 10-Q filing on 11/07/2016 View Form
HALO
Halozyme Therapeutics
08/09/2016 10-Q 10-Q filing on 08/09/2016 View Form
HALO
Halozyme Therapeutics
05/09/2016 10-Q 10-Q filing on 05/09/2016 View Form
HALO
Halozyme Therapeutics
02/29/2016 10-K 10-K filing on 02/29/2016 View Form
HALO
Halozyme Therapeutics
11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
HALO
Halozyme Therapeutics
08/11/2015 10-Q 10-Q filing on 08/11/2015 View Form
HALO
Halozyme Therapeutics
08/10/2015 10-Q 10-Q filing on 08/10/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will VICI Properties Be in 5 Years?
Where Will VICI Properties Be in 5 Years?

VICI Properties (NYSE:VICI) is a real estate investment trust focused…

Where Will Exxon Stock Be in 5 Years?
Where Will Exxon Stock Be in 5 Years?

For sure Exxon Mobil (NYSE: XOM) is no hyped-up AI…

How High Will Dollar General Stock Go?
How High Will Dollar General Stock Go?

Shares of Dollar General (NYSE:DG) have risen significantly in recent…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
64
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
59
SBET alert for Jun 10

SharpLink Gaming [SBET] is up 7.99% over the past day.

Buy
85
ASTS alert for Jun 10

AST SpaceMobile [ASTS] is up 1.58% over the past day.

Buy
69
CCJ alert for Jun 10

Cameco [CCJ] is down 5.69% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock